Moderna (MRNA) Announces Positive Top Line Data from Phase 2/3 Study of COVID-19 Vaccine in Children 6 to 11 Years of Age

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/4/2026

1. KRG
2. SPY
3. SKA-B
4. PBA
5. ALAR
6. CCH:LN
7. META
8. CCHGY
9. PRY:IM
10. PRYMY

Go back to Moderna (MRNA) Announces Positive Top Line Data from Phase 2/3 Study of COVID-19 Vaccine in Children 6 to 11 Years of Age

Moderna (MRNA) Enters MOU to Supply up to 110M COVID-19 Vaccine Doses to the African Union

October 26, 2021 5:50 AM EDT

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a new Memorandum of Understanding (MoU) to make up to 110 million doses... More